FDAsafety guidance54% confidence
FDA AP — HYDROMORPHONE HYDROCHLORIDE (SUPPL)
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as Hikma.
Regulatory Analysis
Application ANDA074653. Sponsor: HIKMA. Submission status: AP. Submission type: SUPPL. Active ingredients: HYDROMORPHONE HYDROCHLORIDE.
Supporting Context
- Therapeutic area
- Pain Management · Opioid
- Sub-indication
- Pain
Related signal: Hikma's ANDA090964 for Oxymorphone Hydrochloride Receives AP Status